Here we have shown that MYCN imparts neuroblastoma tumor-like characteristics, including enhanced proliferation, neural lineage commitment, and higher rates of cell death, to multipotent sympathoadrenal progenitor cells. Here, MYCN is linked to neuroblastoma.